Amanote Research
Register
Sign In
Cost-Effectiveness Analysis of Bisphosphonates for Secondary Prevention of Hip Fracture in Taiwan
Value in Health
- United Kingdom
doi 10.1016/j.jval.2015.03.942
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2015
Authors
P. Lo
Y. Wen
Y. Tsai
Publisher
Elsevier BV
Related search
Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms46 - Cost-Effectiveness of Primary Prevention for Osteoporotic Hip Fractures in Elderly Women
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv76 - Cost-Effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
845 Cost-Effectiveness Analysis in Fire Prevention
Injury Prevention
Environmental
Public Health
Occupational Health
Pms49 - Cost-Effectiveness of Fracture Prevention Provided to Elderly Living in the Community
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Cost of Illness Attributable to Diabetic Foot and Cost-Effectiveness of Secondary Prevention in Peru
BMC Health Services Research
Health Policy
Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Pmd73 - Economic Impact of the Treatment of Primary Open-Angle Glaucoma on Hip Fracture: A Cost-Effectiveness Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Antiretroviral Therapy for Prevention
Current HIV Research
Virology
Infectious Diseases
